• News
  • SAN DIEGO
  • BioTech

ViaCyte appoints Mark Foletta to board

San Diego-based ViaCyte Inc., a regenerative medicine company developing a cell therapy for treating diabetes, announced that Mark Foletta has been appointed to its board of directors.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!